InsiderTrades.com logo
140% Yields From Stocks Like Tesla? Here's How (Black Friday Special)
From Investors Alley   |   Ad
140% Dividends from stocks like Tesla? Discover How for Just $9! For Black Friday, get the full details of an unique dividend strategy that works with giants like Tesla, Apple, and Amazon - at a 82% discount! Don't miss out on this special offer.
Click now to learn how to have the chance at 140% yields before time runs out!

MREO Insider Trading

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $1,279,046.33

Mereo BioPharma Group Insider Trading History Chart

This chart shows the insider buying and selling history at Mereo BioPharma Group by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Mereo BioPharma Group Share Price & Price History

Current Price: $3.38
Price Change: ▼ Price Decrease of -0.34 (-9.14%)
As of 11/25/2024 01:00 AM ET

This chart shows the closing price history over time for MREO up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
140% Yields From Stocks Like Tesla? Here's How (Black Friday Special)
From Investors Alley   |   Ad
140% Dividends from stocks like Tesla? Discover How for Just $9! For Black Friday, get the full details of an unique dividend strategy that works with giants like Tesla, Apple, and Amazon - at a 82% discount! Don't miss out on this special offer.
Click now to learn how to have the chance at 140% yields before time runs out!

Mereo BioPharma Group Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/12/2024Charles SermonGeneral CounselSell9,980$4.47$44,610.60240,007View SEC Filing Icon  
9/12/2024Christine Ann FoxCFOSell9,128$4.47$40,802.16108,443View SEC Filing Icon  
9/12/2024Denise Scots-KnightCEOSell28,611$4.47$127,891.17868,967View SEC Filing Icon  
9/12/2024John A LewickiInsiderSell5,212$4.47$23,297.6489,567View SEC Filing Icon  
8/22/2024Deepika PakianathanDirectorSell105,244$4.43$466,230.92View SEC Filing Icon  
6/25/2024Charles SermonGeneral CounselSell14,202$3.69$52,405.38216,574View SEC Filing Icon  
6/25/2024Christine Ann FoxCFOSell12,990$3.69$47,933.1087,010View SEC Filing Icon  
6/25/2024Denise Scots-KnightCEOSell40,712$3.69$150,227.28801,791View SEC Filing Icon  
6/25/2024John A LewickiInsiderSell7,416$3.69$27,365.0465,587View SEC Filing Icon  
5/22/2024Alexandra Hughes-WilsonInsiderSell100,432$2.97$298,283.0432,568View SEC Filing Icon  
See Full Table
"This Could Be Worse Than the Great Depression, the Dot-Com Crash, and the 2008 Crisis Combined"
From Stansberry Research   |   Ad
What Are These Billionaire Investors Afraid Of? Billionaires Warren Buffett, Stanley Druckenmiller, George Soros, and David Tepper have all sold off massive U.S. stock positions, including shares of Nvidia, Apple, and Bank of America. Billionaire Ray Dalio, who runs one of the world’s most successful hedge funds, says, “Things are going to get worse for our economy.” What are these billionaires so worried about?
Click here to see why experts and insiders may be preparing for the biggest financial crisis of the

SEC Filings (Institutional Ownership Changes) for Mereo BioPharma Group (NASDAQ:MREO)

62.83% of Mereo BioPharma Group stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at MREO by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Mereo BioPharma Group Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/15/2024Frazier Life Sciences Management L.P.5,097,779$20.95M0.8%+15.8%3.635%Search for SEC Filing on Google Icon
11/15/2024State Street Corp47,561$0.20M0.0%N/A0.034%Search for SEC Filing on Google Icon
11/15/2024Polar Asset Management Partners Inc.198,300$0.82M0.0%+36.0%0.141%Search for SEC Filing on Google Icon
11/15/2024Janus Henderson Group PLC12,345,866$50.87M0.0%+56.7%8.802%Search for SEC Filing on Google Icon
11/15/2024Clearline Capital LP3,244,334$13.33M0.6%-2.5%2.313%Search for SEC Filing on Google Icon
11/14/2024Fred Alger Management LLC102,582$0.42M0.0%+108.1%0.073%Search for SEC Filing on Google Icon
11/14/2024Verition Fund Management LLC110,004$0.45M0.0%-51.4%0.078%Search for SEC Filing on Google Icon
11/14/2024Acuta Capital Partners LLC1,260,700$5.18M4.2%+86.2%0.899%Search for SEC Filing on Google Icon
11/12/2024HealthInvest Partners AB200,000$0.82M0.4%N/A0.143%Search for SEC Filing on Google Icon
11/5/2024GSA Capital Partners LLP67,069$0.28M0.0%N/A0.048%Search for SEC Filing on Google Icon
10/7/2024GAMMA Investing LLC10,693$44K0.0%+58.1%0.008%Search for SEC Filing on Google Icon
8/16/2024Perceptive Advisors LLC1,253,250$4.51M0.1%N/A0.894%Search for SEC Filing on Google Icon
8/16/2024Forefront Analytics LLC36,231$0.13M0.1%-17.3%0.026%Search for SEC Filing on Google Icon
8/16/2024Frazier Life Sciences Management L.P.4,401,371$15.85M0.7%N/A3.138%Search for SEC Filing on Google Icon
8/15/2024Blue Owl Capital Holdings LP897,809$3.23M0.9%N/A0.640%Search for SEC Filing on Google Icon
8/15/2024The Manufacturers Life Insurance Company14,621$53K0.0%-87.7%0.010%Search for SEC Filing on Google Icon
8/15/2024Millennium Management LLC3,201,705$11.53M0.0%+46.9%2.283%Search for SEC Filing on Google Icon
8/15/2024Deerfield Management Company L.P. Series C6,710,429$24.16M0.4%N/A4.784%Search for SEC Filing on Google Icon
8/14/2024Fred Alger Management LLC49,304$0.18M0.0%-74.7%0.035%Search for SEC Filing on Google Icon
8/14/2024Marshall Wace LLP1,144,051$4.12M0.0%N/A0.816%Search for SEC Filing on Google Icon
8/14/2024Integral Health Asset Management LLC1,775,000$6.39M0.6%+86.8%1.266%Search for SEC Filing on Google Icon
8/13/2024Rubric Capital Management LP15,307,347$55.11M1.4%+12.9%10.914%Search for SEC Filing on Google Icon
8/9/2024Renaissance Technologies LLC1,762,003$6.34M0.0%+5.4%1.256%Search for SEC Filing on Google Icon
8/7/2024Monaco Asset Management SAM348,128$1.25M0.2%-14.0%0.248%Search for SEC Filing on Google Icon
8/7/2024PFG Investments LLC17,000$61K0.0%-45.5%0.012%Search for SEC Filing on Google Icon
8/1/2024Rhumbline Advisers6,958$25K0.0%+70.9%0.005%Search for SEC Filing on Google Icon
5/16/2024Janus Henderson Group PLC5,120,573$16.95M0.0%N/A3.651%Search for SEC Filing on Google Icon
5/16/2024Knoll Capital Management LLC260,470$0.86M0.5%+62.3%0.186%Search for SEC Filing on Google Icon
5/15/2024Price T Rowe Associates Inc. MD991,971$3.27M0.0%N/A0.707%Search for SEC Filing on Google Icon
5/13/2024Index Fund Advisors Inc.30,000$99K0.0%N/A0.021%Search for SEC Filing on Google Icon
5/9/2024Monaco Asset Management SAM405,000$1.34M0.4%-40.1%0.324%Search for SEC Filing on Google Icon
5/8/2024Advisors Preferred LLC8,262$28K0.0%N/A0.007%Search for SEC Filing on Google Icon
5/7/2024SG Americas Securities LLC16,221$54K0.0%N/A0.013%Search for SEC Filing on Google Icon
5/1/2024BNP Paribas Financial Markets17,435$58K0.0%+581,066.7%0.014%Search for SEC Filing on Google Icon
2/15/2024Forefront Analytics LLC36,124$83K0.0%-45.0%0.029%Search for SEC Filing on Google Icon
2/14/2024Rubric Capital Management LP13,552,997$31.31M0.6%+16.7%10.843%Search for SEC Filing on Google Icon
2/13/2024NEOS Investment Management LLC351,905$0.81M0.1%+751.5%0.282%Search for SEC Filing on Google Icon
2/9/2024Primecap Management Co. CA54,000$0.13M0.0%-31.6%0.043%Search for SEC Filing on Google Icon
2/7/2024Monaco Asset Management SAM676,494$1.56M0.5%+13.6%0.541%Search for SEC Filing on Google Icon
2/2/2024Golden State Equity Partners20,300$47K0.0%+41.0%0.016%Search for SEC Filing on Google Icon
1/31/2024abrdn plc1,551,082$3.58M0.0%N/A1.241%Search for SEC Filing on Google Icon
1/18/2024Clear Harbor Asset Management LLC59,754$0.14M0.0%-6.3%0.048%Search for SEC Filing on Google Icon
11/15/2023Tejara Capital Ltd3,215,001$4.15M2.4%+5.8%2.572%Search for SEC Filing on Google Icon
11/15/2023Rock Springs Capital Management LP7,676,481$9.90M0.3%+9.0%6.142%Search for SEC Filing on Google Icon
11/15/2023Adage Capital Partners GP L.L.C.800,000$1.03M0.0%N/A0.640%Search for SEC Filing on Google Icon
11/14/2023683 Capital Management LLC6,000,000$7.74M0.6%+11.1%4.800%Search for SEC Filing on Google Icon
11/14/2023Primecap Management Co. CA79,000$0.10M0.0%-49.9%0.063%Search for SEC Filing on Google Icon
11/13/2023Tejara Capital Ltd3,215,001$4.15M3.1%+5.8%2.572%Search for SEC Filing on Google Icon
11/9/2023Formidable Asset Management LLC331,914$0.43M0.1%N/A0.266%Search for SEC Filing on Google Icon
11/8/2023Forefront Analytics LLC65,649$85K0.0%-20.7%0.053%Search for SEC Filing on Google Icon
11/7/2023Monaco Asset Management SAM595,729$0.77M0.2%-15.6%0.477%Search for SEC Filing on Google Icon
11/6/2023Privium Fund Management UK Ltd24,726$32K0.0%-86.0%0.020%Search for SEC Filing on Google Icon
10/26/2023Clear Harbor Asset Management LLC63,754$82K0.0%+12.3%0.051%Search for SEC Filing on Google Icon
8/14/2023683 Capital Management LLC5,400,000$7.13M0.5%+170.0%4.320%Search for SEC Filing on Google Icon
8/14/2023Rock Springs Capital Management LP7,042,391$9.30M0.2%+12.8%5.634%Search for SEC Filing on Google Icon
8/14/2023Mangrove Partners5,531,547$7.30M0.5%N/A4.426%Search for SEC Filing on Google Icon
8/11/2023Rubric Capital Management LP11,616,120$15.33M0.7%+12.1%9.294%Search for SEC Filing on Google Icon
8/11/2023Tejara Capital Ltd3,037,971$4.01M2.0%+24.7%2.431%Search for SEC Filing on Google Icon
8/8/2023Monaco Asset Management SAM705,729$0.93M0.3%-46.4%0.565%Search for SEC Filing on Google Icon
8/3/2023PFG Investments LLC31,500$42K0.0%-33.7%0.025%Search for SEC Filing on Google Icon
7/26/2023Privium Fund Management B.V.177,200$0.23M0.1%N/A0.142%Search for SEC Filing on Google Icon
7/21/2023Clear Harbor Asset Management LLC56,754$75K0.0%-29.7%0.045%Search for SEC Filing on Google Icon
5/12/2023Tejara Capital Ltd2,435,806$1.72M0.9%+11.3%1.949%Search for SEC Filing on Google Icon
5/12/2023Forefront Analytics LLC83,700$59K0.0%+13.9%0.067%Search for SEC Filing on Google Icon
5/11/2023PFG Investments LLC47,500$34K0.0%N/A0.038%Search for SEC Filing on Google Icon
5/9/2023Formidable Asset Management LLC331,914$0.23M0.0%+15.2%0.266%Search for SEC Filing on Google Icon
2/14/2023683 Capital Management LLC125,000$94K0.0%N/A0.100%Search for SEC Filing on Google Icon
2/13/2023Forefront Analytics LLC73,500$55K0.0%-34.8%0.059%Search for SEC Filing on Google Icon
2/3/2023Monaco Asset Management SAM2,049,661$1.54M0.4%+998.1%1.640%Search for SEC Filing on Google Icon
1/31/2023Monaco Asset Management SAM2,049,661$1.54M0.5%+998.1%1.640%Search for SEC Filing on Google Icon
1/20/2023Clear Harbor Asset Management LLC84,000$63K0.0%-42.1%0.067%Search for SEC Filing on Google Icon
11/14/2022Point72 Asset Management L.P.9,829,354$8.46M0.0%-2.1%7.864%Search for SEC Filing on Google Icon
11/14/2022Clearline Capital LP3,957,135$3.41M0.4%+29.4%3.166%Search for SEC Filing on Google Icon
11/14/2022Rubric Capital Management LP10,366,120$8.93M0.4%-38.1%8.294%Search for SEC Filing on Google Icon
11/14/2022Forefront Analytics LLC112,800$96K0.1%+48.7%0.090%Search for SEC Filing on Google Icon
11/7/2022Virtu Financial LLC33,880$29K0.0%N/A0.027%Search for SEC Filing on Google Icon
11/3/2022Barclays PLC39,470$34K0.0%+97.4%0.032%Search for SEC Filing on Google Icon
11/1/2022Privium Fund Management UK Ltd177,200$0.15M0.2%N/A0.142%Search for SEC Filing on Google Icon
10/31/2022Monaco Asset Management SAM186,656$0.16M0.1%N/A0.160%Search for SEC Filing on Google Icon
10/25/2022Clear Harbor Asset Management LLC145,000$0.13M0.0%-10.5%0.124%Search for SEC Filing on Google Icon
8/16/2022Formidable Asset Management LLC275,556$0.31M0.1%N/A0.236%Search for SEC Filing on Google Icon
8/16/2022DAFNA Capital Management LLC1,096,513$1.23M0.3%-9.9%0.937%Search for SEC Filing on Google Icon
8/15/2022Clearline Capital LP3,058,596$3.43M0.4%+135.0%2.615%Search for SEC Filing on Google Icon
8/15/2022Point72 Asset Management L.P.10,035,970$11.24M0.0%-12.7%8.579%Search for SEC Filing on Google Icon
8/12/2022Ikarian Capital LLC615,856$0.20M0.0%-32.8%0.526%Search for SEC Filing on Google Icon
8/11/2022Primecap Management Co. CA321,660$0.36M0.0%-2.8%0.275%Search for SEC Filing on Google Icon
8/10/2022Forefront Analytics LLC75,850$83K0.0%N/A0.065%Search for SEC Filing on Google Icon
7/25/2022Silverarc Capital Management LLC156,195$0.18M0.1%-33.7%0.134%Search for SEC Filing on Google Icon
7/20/2022Clear Harbor Asset Management LLC162,000$0.19M0.0%+589.4%0.138%Search for SEC Filing on Google Icon
5/17/2022Rock Springs Capital Management LP6,074,943$6.80M0.2%+8.8%5.193%Search for SEC Filing on Google Icon
5/16/2022Clearline Capital LP1,301,783$1.46M0.2%+89.7%1.113%Search for SEC Filing on Google Icon
5/16/2022J. Goldman & Co LP217,051$0.24M0.0%+221.6%0.186%Search for SEC Filing on Google Icon
5/16/2022Eversept Partners LP370,170$0.42M0.0%+42.7%0.316%Search for SEC Filing on Google Icon
5/16/2022Maven Securities LTD544,458$0.61M0.0%+72.6%0.465%Search for SEC Filing on Google Icon
2/15/2022Rubric Capital Management LP14,914,447$23.86M1.1%+32.0%22.001%Search for SEC Filing on Google Icon
2/15/2022Sender Co & Partners Inc.333,904$0.53M0.3%N/A0.493%Search for SEC Filing on Google Icon
2/15/2022Shay Capital LLC48,052$77K0.0%N/A0.071%Search for SEC Filing on Google Icon
2/15/2022Commodore Capital LP1,954,970$3.13M0.7%-0.9%2.884%Search for SEC Filing on Google Icon
2/14/2022Clearline Capital LP686,292$1.10M0.1%N/A1.012%Search for SEC Filing on Google Icon
2/14/2022Bluefin Capital Management LLC37,300$60K0.0%N/A0.055%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Mereo BioPharma Group logo
Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom, the United States, and internationally. It develops Etigilimab (MPH-313), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the treatment of tumors. The company is also developing Navicixizumab (OMP-305B83), which has completed Phase 1b clinical trials for the treatment of the late line ovarian cancer; Acumapimod (BCT-197), a p38 MAP kinase inhibitor that is in Phase II clinical trials to treat acute exacerbations of chronic obstructive pulmonary disease; and Leflutrozole (BGS-649), an oral aromatase inhibitor for the treatment of hypogonadotropic hypogonadism which is in Phase 2 trials. In addition, it develops rare disease product candidates, including Setrusumab (BPS-804), an antibody for the treatment of osteogenesis imperfecta; and Alvelestat (MPH-966), an oral small molecule that is in Phase II clinical trial to treat Alpha-1 anti-trypsin deficiency. The company has a license agreement with Feng Biosciences for the development and commercialization of navicixizumab; license agreement with ReproNovo for the development and commercialization of leflutrozole; licensing agreement with AstraZeneca; and license agreement with Ultragenyx Pharmaceutical Inc. to develop and commercialize setrusumab. Mereo BioPharma Group plc was incorporated in 2015 and is headquartered in London, the United Kingdom.
Read More on Mereo BioPharma Group

Today's Range

Now: $3.38
Low: $3.36
High: $3.82

50 Day Range

MA: $4.13
Low: $3.33
High: $4.62

52 Week Range

Now: $3.38
Low: $3.17
High: $5.02

Volume

1,121,294 shs

Average Volume

809,874 shs

Market Capitalization

$524.41 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Mereo BioPharma Group?

Mereo BioPharma Group's top insider investors include:
  1. Denise Scots-Knight (CEO)
  2. Charles Sermon (General Counsel)
  3. Christine Ann Fox (CFO)
  4. John A Lewicki (Insider)
  5. Alexandra Hughes-Wilson (Insider)
  6. Deepika Pakianathan (Director)
Learn More about top insider investors at Mereo BioPharma Group.

Who are the major institutional investors of Mereo BioPharma Group?

Mereo BioPharma Group's top institutional investors include:
  1. Janus Henderson Group PLC — 8.80%
  2. Frazier Life Sciences Management L.P. — 3.63%
  3. Clearline Capital LP — 2.31%
  4. Acuta Capital Partners LLC — 0.90%
  5. Jane Street Group LLC — 0.00%
  6. HealthInvest Partners AB — 0.14%
Learn More about top institutional investors of Mereo BioPharma Group stock.

Which major investors are selling Mereo BioPharma Group stock?

In the previous quarter, MREO stock was sold by these institutional investors:
  1. Verition Fund Management LLC
  2. Clearline Capital LP
  3. Jane Street Group LLC
Within the last year, company insiders that have sold Mereo BioPharma Group company stock include:
  1. Denise Scots-Knight (CEO)
  2. Charles Sermon (General Counsel)
  3. Christine Ann Fox (CFO)
  4. John A Lewicki (Insider)
  5. Alexandra Hughes-Wilson (Insider)
  6. Deepika Pakianathan (Director)
Learn More investors selling Mereo BioPharma Group stock.

Which major investors are buying Mereo BioPharma Group stock?

During the last quarter, MREO stock was bought by institutional investors including:
  1. Janus Henderson Group PLC
  2. Frazier Life Sciences Management L.P.
  3. Acuta Capital Partners LLC
  4. HealthInvest Partners AB
  5. GSA Capital Partners LLP
  6. Fred Alger Management LLC
  7. Polar Asset Management Partners Inc.
  8. State Street Corp
140% Yields From Stocks Like Tesla? Here's How (Black Friday Special)
From Investors Alley   |   Ad
140% Dividends from stocks like Tesla? Discover How for Just $9! For Black Friday, get the full details of an unique dividend strategy that works with giants like Tesla, Apple, and Amazon - at a 82% discount! Don't miss out on this special offer.
Click now to learn how to have the chance at 140% yields before time runs out!